Topline results of a Phase II trial reveal that VX-993 did not meet its primary endpoints, meaning Vertex will discontinue its development.

India was slapped with an additional set of tariffs at the rate of 15 per cent tariffs making the total tariff for India 25 ...

The United States 25 per cent tariff on Indian imports is set to take effect on August 7. PHDCCI projected that the tariffs can impact the import of engineering goods ($1.8 billion), electronic goods ...

These tariffs would drastically undermine the price advantage Indian drug makers currently enjoy in the US, especially in ...

Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...

The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...

All three major U.S. indexes finished in the red, after a disappointing services-sector report and tariff news weighed on investor sentiment. The ISM services-sector index provided another sign that ...

Discover key insights from Personalis Inc.'s Q2 2025 earnings call, including clinical growth, NeXT Personal adoption, Tempus partnership, and ...

Kennedy said Tuesday that the terminated contracts were worth nearly $500 million. Among them is an award to the University of Texas Medical Branch and the biotechnology company Moderna to develop an ...

The Trump administration says it's aiming to lower drug costs for Americans. It's given drug companies 60 days to lower ...

President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical ...

Holivita from Holiverse uses blockchain-secured data to give users control, enabling personalized preventive healthcare and ...